9th Edition of Global Conference on

Pharmaceutics and Novel Drug Delivery Systems

June 12-13, 2023 | Rome, Italy

Pharmacologic Treatments for COVID-19

Pharmacologic Treatments for COVID-19

The pandemic of coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses an unprecedented challenge in terms of identifying effective prevention and treatment medications. Although some clinical research on traditional antiviral medicines have been undertaken around the world, the outcomes are still inconclusive. In general, the optimal treatment for COVID-19 patients is determined by a number of characteristics, including the disease's stage and symptoms. Administration of drugs among different patient populations may be difficult due to variances in individual genetics in drug metabolism as well as the diversity of immune responses to the coronavirus.

Committee Members
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Richard Denk

Richard Denk

SKAN AG, Switzerland
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Thomas J Webster

Thomas J Webster

Hebei University of Technology, China
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Autonomous University of Baja California, Mexico
PHARMACEUTICS 2023 Speakers
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Richard Denk

Richard Denk

SKAN AG, Switzerland
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Autonomous University of Baja California, Mexico
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Raphael Mechoulam

Raphael Mechoulam

The Hebrew University of Jerusalem, Israel
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2023 - Pierfrancesco Morganti

Pierfrancesco Morganti

Academy of History of Healthcare Art, Italy

Submit your abstract Today

Watsapp